![](https://thepharmadata.com/wp-content/uploads/2024/07/Autobahn-Therapeutics-Raises-100-Million-in-Oversubscribed-Series-C-for-CNS-Disorder-Treatments_11zon-768x512.webp)
Autobahn Therapeutics Raises $100 Million in Oversubscribed Series C for CNS Disorder Treatments
Autobahn Therapeutics, a biotech firm focused on innovative treatments for neuropsychiatric and neuroimmunologic disorders, has closed an oversubscribed $100 million Series C financing round. The funding was led by Newpath…
![](https://thepharmadata.com/wp-content/uploads/2024/07/PK-MED-Secures-E1.5M-Bpifrance-Funding-for-Cell-Homing-Implant-in-Bone-Marrow-Transplants-768x512.webp)
PK MED Secures €1.5M Bpifrance Funding for Cell-Homing Implant in Bone Marrow Transplants
PK MED, a French biotech company established in 2019 by Truffle Capital, has secured €1.5 million in non-dilutive DeepTech financing from Bpifrance. This funding will drive the development of PKM-02,…
![](https://thepharmadata.com/wp-content/uploads/2024/07/PROTEINA-Co.-Announces-Breakthrough-in-Nature-Biomedical-Engineering_11zon-768x512.webp)
PROTEINA Co. Announces Breakthrough in Nature Biomedical Engineering
PROTEINA Co., Ltd., in partnership with Seoul National University (SNU) and Seoul National University Hospital (SNUH), has announced groundbreaking research published in Nature Biomedical Engineering. The study introduces a novel…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Nuvation-Bio-Updates-and-Presentations-on-ROS1-Inhibitor-Taletrectinib_11zon-768x512.webp)
Nuvation Bio Updates and Presentations on ROS1 Inhibitor Taletrectinib
Nuvation Bio, a late-stage global biopharmaceutical company focused on oncology, has announced several updates for its taletrectinib program. Data from the global, pivotal Phase 2 TRUST-II study will be presented…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Verastem-Oncology-Announces-Public-Offering-of-Stock-and-Warrants_11zon-768x512.jpg)
Verastem Oncology Announces Public Offering of Stock and Warrants
Verastem Oncology, a biopharmaceutical company focused on developing new cancer treatments, announced its intention to offer and sell shares of common stock and accompanying warrants to purchase common stock. The…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Verastem-Oncology-Announces-55M-Public-Offering_11zon-768x512.webp)
Verastem Oncology Announces $55M Public Offering
Verastem Oncology, a biopharmaceutical company focused on cancer treatments, announced the pricing of an underwritten public offering. The offering includes 13,333,334 shares of common stock and accompanying warrants to purchase…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Pharmaceutical-Leader-Kare-Schultz-Appointed-to-Hims-Hers-Board-768x512.webp)
Pharmaceutical Leader Kåre Schultz Appointed to Hims & Hers Board
Hims & Hers Health, a leading health and wellness platform, has announced the appointment of Kåre Schultz to its Board of Directors. Schultz, known for his extensive global expertise in…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Lario-Therapeutics-Receives-6M-Grant-from-Michael-J.-Fox-Foundation-for-Parkinsons-Research-768x512.webp)
Lario Therapeutics Receives $6M Grant from Michael J. Fox Foundation for Parkinson’s Research
Lario Therapeutics Secures $6M Grant from Michael J. Fox Foundation for Parkinson’s Research Lario Therapeutics, a biopharmaceutical company focused on pioneering precision medicines for neurological and epileptic disorders, has announced…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Gilead-and-Elton-John-AIDS-Foundation-Extend-RADIAN-Partnership-to-Tackle_11zon-768x512.webp)
Gilead and Elton John AIDS Foundation Extend RADIAN Partnership to Tackle HIV in Eastern Europe and Central Asia
Gilead Sciences, Inc. (Nasdaq: GILD) and the Elton John AIDS Foundation (EJAF) have announced a five-year extension of the RADIAN® partnership to address the growing HIV crisis in Eastern Europe…
![](https://thepharmadata.com/wp-content/uploads/2024/07/AHF-Press-Conference-Advocates-Urge-Gilead-to-Prioritize-Lives-Over-Profits-at-AIDS-2024_11zon-768x512.webp)
AHF Press Conference: Advocates Urge Gilead to Prioritize Lives Over Profits at AIDS 2024
AIDS Healthcare Foundation (AHF) will hold an in-person and virtual press conference at the AHF booth (#111) during the 2024 International AIDS Conference (AIDS 2024) on Tuesday, July 23, at…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Rusan-Pharmas-Ankleshwar-API-Plant-Receives-USFDA-GMP-Approval_11zon-768x512.webp)
Rusan Pharma’s Ankleshwar API Plant Receives USFDA GMP Approval
Rusan Pharma, an India-based pharmaceutical company specializing in addiction treatment and pain management, recently announced that the United States Food and Drug Administration (USFDA) has granted Good Manufacturing Practice (GMP)…
![](https://thepharmadata.com/wp-content/uploads/2024/07/Ionis-Finishes-Enrollment-in-Key-Trial-Assessing-Zilganersen-for-Alexander-Disease_11zon-768x512.webp)
Ionis Finishes Enrollment in Key Trial Assessing Zilganersen for Alexander Disease
Ionis Pharmaceuticals today revealed that it has finalized enrollment in its pivotal trial evaluating zilganersen (ION373), an investigational RNA-targeted therapy aimed at treating children and adults with Alexander disease (AxD),…